Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance (VOYAGE)
VOYAGE- Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance
Sponsor: Azienda Ospedaliera Universitaria Senese
This PHASE4 trial investigates Myocardial Fibrosis and Ventricular Tachycardia and is currently completed. Azienda Ospedaliera Universitaria Senese leads this study, which shows 6 recorded versions since 2020 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE4
Status: Unknown → Completed · Phase: PHASE3 → PHASE4
-
Sep 2025 — Jan 2026 [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Sep 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 1 earlier version
-
Feb 2021 — Sep 2023 [monthly]
Recruiting PHASE3
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Azienda Ospedaliera Universitaria Senese
- Azienda Ospedaliero, Universitaria Pisana
- Azienda USL Toscana Nord Ovest
- Azienda USL Toscana Sud Est
- Centro Medico Teknon
- Fondazione Toscana Gabriele Monasterio
For direct contact, visit the study record on ClinicalTrials.gov .